Search
for

    Sort by

    Research

    120-150 / 1000+ results
      The Role of Vimentin in Tissue Repair and Cell Growth

      research The Role of Vimentin in Tissue Repair and Cell Growth

      January 2023 in “Åbo Akademi University Research Portal”
      This study found that vimentin is essential for proper wound healing and cell growth by influencing EMT signaling and mTOR activity in mice.
      References

      research References

      January 2018
      This reference list, part of a book by Alex Gough, Alison Thomas, and Dan O'Neill, compiles citations from veterinary journals on various canine and feline health issues, but reports no new research findings.
      AAPS and PSRC 2016 Abstract Supplement

      research AAPS and PSRC 2016 Abstract Supplement

      April 2016 in “Plastic and reconstructive surgery. Global open”
      This article from the PRS Global Open and ASPS Education Network does not present any new research findings; it likely serves as an introductory or descriptive overview.
      New Proprietary Brands: Gabapentin

      research NEW PROPRIETARY BRANDS: Gabapentin

      October 2004 in “Australian Prescriber”
      This article discusses the role of lifestyle changes and medication like metformin in managing insulin resistance and cardiovascular risk in women with polycystic ovary syndrome but reports no new clinical results.
      New Drugs: Iobenguane Sulfate

      research New drugs: Iobenguane sulfate

      October 2004 in “Australian Prescriber”
      This discussion reviews the lack of long-term clinical studies on metformin's cardiovascular benefits in women with polycystic ovary syndrome, advocating for lifestyle changes to improve insulin sensitivity.
      New Proprietary Brands: Cephalexin

      research NEW PROPRIETARY BRANDS: Cephalexin

      October 2004 in “Australian Prescriber”
      This article discusses the management of long-term cardiovascular risks in women with polycystic ovary syndrome and suggests that lifestyle changes may be more effective than metformin in reducing the incidence of type 2 diabetes.
      New Drugs: Agalsidase Beta

      research New drugs: Agalsidase beta

      October 2004 in “Australian Prescriber”
      This article discusses the long-term cardiovascular risks associated with polycystic ovary syndrome and highlights the greater effectiveness of lifestyle changes compared to metformin in preventing type 2 diabetes, but provides no new clinical outcomes.
      New Formulations: Sodium Cromoglycate

      research NEW FORMULATIONS: Sodium cromoglycate

      October 2004 in “Australian Prescriber”
      This review discusses the management of long-term risks in women with polycystic ovary syndrome, recommending lifestyle changes to improve insulin sensitivity over relying solely on metformin, and reports no new clinical results.
      New Proprietary Brands: Cefaclor Monohydrate

      research NEW PROPRIETARY BRANDS: Cefaclor monohydrate

      October 2004 in “Australian Prescriber”
      This article discusses the role of insulin resistance in cardiovascular risk and suggests that lifestyle changes may be more beneficial than metformin in managing polycystic ovary syndrome; it reports no new clinical results.
      New Formulations: Glatiramer Acetate

      research NEW FORMULATIONS: Glatiramer acetate

      October 2004 in “Australian Prescriber”
      This abstract reviews the management of polycystic ovary syndrome and highlights the potential benefits of lifestyle changes over metformin in reducing type 2 diabetes risk, yet reports no new clinical outcomes.
      New Drugs: Agalsidase Alfa

      research New drugs: Agalsidase alfa

      October 2004 in “Australian Prescriber”
      This review discusses the lack of long-term clinical studies on metformin's cardiovascular benefits in women with polycystic ovary syndrome, highlighting lifestyle changes as a crucial management strategy for reducing associated risks.
      Androgenetic Alopecia and Insulin Resistance: Are They Truly Associated?

      research Androgenetic alopecia and insulin resistance: are they truly associated?

      35 citations , March 2011 in “International Journal of Dermatology”
      This study concluded that patients with metabolic syndrome, regardless of androgenetic alopecia presence, were more insulin resistant than those with only androgenetic alopecia or healthy controls, indicating no true association between alopecia and insulin resistance.
      Syphilis: Today

      research Syphilis: today

      2 citations , October 2010 in “Reviews in Medical Microbiology”
      This review discusses syphilis and reports no new clinical findings; it highlights the need for improved prevention and diagnosis to address increasing infection rates globally and in Hungary.
      Insulin Resistance and Polycystic Ovary Syndrome

      research Insulin Resistance and Polycystic Ovary Syndrome

      November 2004 in “John Wiley & Sons, Ltd eBooks”
      This chapter reviews polycystic ovary syndrome (PCOS), focusing on its definition, causes, and treatment approaches, but reports no new research findings.
      Molecular Pathology of Skin Adnexal Tumors

      research Molecular pathology of skin adnexal tumours

      16 citations , July 2021 in “Histopathology”
      This review discusses recent findings on molecular changes in cutaneous adnexal tumours and reports novel markers and pathways involved, highlighting the diverse oncogenic drivers and tumour suppressor alterations.
      Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review

      research Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review

      5 citations , June 2025 in “Advances in Therapy”
      This narrative review reports that metformin, traditionally used for type 2 diabetes management, may offer therapeutic benefits for various skin disorders, such as acne, rosacea, and psoriasis, due to its anti-inflammatory and other beneficial properties, warranting further exploration in dermatology.
      The Rotterdam Study: Objectives And Design Update

      research The Rotterdam Study: objectives and design update

      1415 citations , October 2007 in “European Journal of Epidemiology”
      This article reviews the objectives and design of the Rotterdam Study and summarizes key findings across its focus on various diseases, without reporting new experimental results.
      Cutaneous Wound Healing: Recruiting Developmental Pathways for Regeneration

      research Cutaneous wound healing: recruiting developmental pathways for regeneration

      471 citations , October 2012 in “Cellular and Molecular Life Sciences”
      This review discusses the roles of key developmental signaling pathways in mammalian skin repair compared to skin development, and suggests these insights could lead to better wound healing therapies, but it reports no new findings.
      Obesity and the Skin: Skin Physiology and Skin Manifestations of Obesity

      research Obesity and the skin: Skin physiology and skin manifestations of obesity

      405 citations , May 2007 in “Journal of The American Academy of Dermatology”
      This review discusses the profound impact of obesity on skin physiology and dermatologic conditions and reports no new experimental results, recommending awareness and treatment strategy development for obesity-associated dermatoses.
      Interrelation of Immunity and Tissue Repair or Regeneration

      research Interrelation of immunity and tissue repair or regeneration

      252 citations , April 2009 in “Seminars in Cell & Developmental Biology”
      This review discusses the complex role of the immune system in tissue repair and regeneration, highlighting its positive and negative influences but reports no new clinical findings.
      Cutaneous Androgen Metabolism: Basic Research And Clinical Perspectives

      research Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives

      233 citations , November 2002 in “˜The œjournal of investigative dermatology/Journal of investigative dermatology”
      This review explores androgen metabolism in the skin, highlighting enzyme localization and potential implications for treating androgen-dependent skin conditions, but it reports no new clinical results.